Downregulation of CD4 is required for maintenance of viral infectivity of HIV-1  by Tanaka, Masakazu et al.
Downregulation of CD4 is required for maintenance
of viral infectivity of HIV-1
Masakazu Tanaka, Takaharu Ueno, Tomomi Nakahara,1 Kenta Sasaki,
Akinori Ishimoto, and Hiroyuki Sakai*
Laboratory of Gene Analysis, Department of Viral Oncology, Institute for Virus Research, Kyoto University, Sakyo-ku, Kyoto 606-8393, Japan
Received 7 October 2002; returned to author for revision 30 December 2002; accepted 13 January 2003
Abstract
Downregulation of virus receptors on the cell surface is considered to be important in preventing superinfection. HIV-1 encodes multiple
gene products, Env, Vpu, and Nef, involved in downregulation of CD4, a major HIV-1 receptor. We found that simultaneous mutations in
both vpu and nef severely impaired virus replication. We examined the involvement of CD4 downregulation mediated by Vpu and Nef in
the modification of virus infectivity. The mutation in vpu increased CD4 incorporation into virions without affecting the Env content in it,
inhibiting the attachment step of virions to the CD4-positive cell surface. Although a single mutation in nef suppresses virus infectivity via
a CD4-independent mechanism, it could augment CD4 incorporation in virions in combination with a vpu mutation. These results indicated
that CD4 downregulation was necessary for maintenance of Env function in the virion.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
The CD4 molecule is a major receptor for human immu-
nodeficiency virus type 1 (HIV-1) entry (Klatzmann et al.,
1984; Maddon et al., 1986) and plays a central role in
acquired immune deficiency syndrome (AIDS) pathogene-
sis (Bour et al., 1995a). Decline of the CD4-positive cell
population in the peripheral blood mononuclear cells
(PBMCs) is a hallmark for the progression of AIDS. CD4
participates in the essential regulation in both development
and function of the immune system. CD4 binds to the major
histocompatibility complex type II (MHC-II) on antigen-
presenting cells (APCs), which play a pivotal role for the
antigen recognition machinery and activation of T cells
(Weiss and Littman, 1994).
It has been reported that infection of HIV-1 in CD4-
positive helper T cells, which are the major target for HIV-1
infection, induces downregulation of CD4 expression on the
cell surface (Dalgleish et al., 1984; Klatzmann et al., 1984).
Other enveloped viruses are also known to downregulate the
receptor expression on infected cells, which is considered
important in preventing superinfection (Delwart and Panga-
niban, 1989; Steck and Rubin, 1966). In most cases, the
membrane-associated viral protein interacts with its recep-
tor molecule on endoplasmic reticulum (ER) and/or cyto-
plasmic membrane, inducing downregulation of the recep-
tor molecule from the cell surface. In HIV-1, it has been
reported that the Env precursor, gPr160, binds to CD4
molecule in the ER and inhibits its transport to the cell
surface (Cris et al., 1990; Jabbar and Nayak, 1990; Steven-
son et al., 1988). In HIV-1 infections, many reports indicate
that the viral regulatory gene products Vpu and Nef also
participate in CD4 downregulation, in addition to Env
(Chen et al., 1996; Garcia and Miller, 1991; Strebel et al.,
1988). Recently Vpr has also been shown to suppress CD4
expression (Conti et al., 2000), even though there is a
conflicting report (Arganaraz et al., 2002). Therefore, there
appears to be a redundancy of gene function in CD4 down-
regulation. However, the mechanisms of these gene prod-
ucts in CD4 downregulation are functionally independent,
and they act cooperatively to affect CD4 expression.
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Vpu and Env are translated from a bicistronic mRNA
(Schwartz et al., 1990). On the contrary, most HIV-1 genes
are expressed from monocistronic mRNAs, suggesting that
a balanced expression of Vpu and Env is important for their
functions. Vpu is a membrane-associated 16-kDa protein,
which has an N-terminus embedded in the cytoplasmic
membrane. A primary biological function associated with
Vpu is an enhancement of virion release from HIV-1-in-
fected cells (Strebel et al., 1988, 1989). Following this
finding, it was reported that Vpu shortened the half-life of
CD4 molecules, resulting in a reduction of cell-surface CD4
expression in HIV-1-infected cells (Willey, 1992a). Env
precursor, gPr160, is involved in this activity; Vpu recog-
nizes a gPr160/CD4 complex formed in the ER membrane
(Bour et al., 1995b) and tags CD4 with ubiquitin ligase,
TrCP, directing proteasome-dependent degradation of
CD4 (Margottin et al., 1998; Schubert et al., 1998).
Nef is a 27-kDa protein, of which the N-terminus is
myristylated. It has been considered that Nef functions as a
virulence factor for AIDS pathogenesis. Studies with long-
term nonprogressors infected with HIV-1 reveal that dele-
tions in nef are found in significant numbers in these pop-
ulations (Kirchhoff et al., 1995; Mariani et al., 1996). In
addition to that, simian immunodeficiency virus (SIV) Nef
has been reported to play a crucial role in AIDS develop-
ment in infected monkeys (Kestler et al., 1991). An exper-
iment with transgenic mice harboring HIV-1 sequences sug-
gested Nef was responsible for induction of AIDS-like
symptom (Hanna et al., 1998). Although Nef function is
dispensable in a virus replication assay using a T-cell line,
it is required for enhancement of virus replication in
PBMCs and macrophages (de Ronde et al., 1992; Miller et
al., 1994; Spina et al., 1994; Terwilliger et al., 1991).
Nef has been reported to have multiple biological activ-
ities, one of which is downregulation of CD4 (Aiken et al.,
1994; Garcia and Miller, 1991; Piguet et al., 1999b). Nef
associates with CD4 molecules on the cell surface and
directs clathrin-coated pit (CCP)-dependent endocytosis of
CD4, resulting in lysosome-mediated CD4 degradation
(Greenberg et al., 1997b; Mangasarian et al., 1997; Piguet et
al., 1999a). For the sorting of CD4 by Nef, AP-2 has been
reported to be involved (Greenberg et al., 1997a), but the
details of the molecular mechanism remain to be elucidated.
It has been reported that Nef can downregulate the MHC-I
molecule through a distinct molecular pathway (Mangasar-
ian et al., 1999; Riggs et al., 1999; Schwartz et al., 1996).
Besides these activities, Nef has a function to enhance virus
infectivity, by which virion infectivity is augmented by
more than 10-fold in a single round of infection (Aiken and
Trono, 1995; Cowers et al., 1994). The Nef function in virus
infectivity is not dependent on CD4 expression in producer
cells. The regulatory mechanism of virus infectivity by Nef
remains to be further defined.
The fact that CD4 downregulation is mediated by mul-
tiple gene functions in HIV-1 implies that it plays an es-
sential role in HIV-1 replication. Lundquist et al. (2002)
reported that there was a clear correlation between the
activity of Nef in CD4 downregulation and the replication
capacity of the virus in CD4-positive T cells using a series
of nef mutant viruses. However, the mechanism by which
CD4 expression influenced virus infectivity was not fully
documented. Elimination of the virus receptor on the cell
surface makes it possible to avoid multiple superinfection
events. Other reports showed that the accumulation of pro-
viral DNA was caused by superinfection of HIV-1, which
was toxic to the cells, indicating that it might be important
for virus replication to inhibit superinfection (Bergeron and
Sodroski, 1992; Pauza et al., 1990; Robunson and Zinkus,
1990; Somasundaran and Robinson, 1988). Additional re-
ports stated that surface CD4 can be incorporated into viri-
ons, which prevents Env incorporation, resulting in impair-
ment of virion infectivity (Coretes et al., 2002; Lama et al.,
1999). It has also been reported that the cell surface CD4
binds to Env on virions, which inhibits virion release from
the cell surface (Coretes et al., 2002; Ross et al., 1999).
Although the effects of CD4 expression on virus infectivity
have been shown in some experimental conditions, it re-
mains unclear what role the modulation of CD4 expression
plays in virus replication in vivo.
With vpu and nef mutant viruses, we examined the cor-
relation between their effects on virus infectivity and on
modulation of CD4 expression. These results indicated that
Vpu affected the total amount of CD4 molecule, and the vpu
mutation caused incorporation of CD4 into virions, result-
ing in impairment of virus infectivity. The amount of Env in
virions was not affected by the vpu mutation, suggesting
that the reduction of infectivity was due to the inhibition of
attachment process caused by Env–CD4 association on the
virion surface. Nef may function to eliminate cell surface
CD4 expression, which is involved in the inhibition of viral
superinfection.
Results
Vpu-modulated infectivity of virus produced from
CD4-positive cells
Multiple gene products of HIV-1, Vpu, Nef, and Env, act
cooperatively in downregulation of CD4, the major receptor
for HIV-1 infection (Chen et al., 1996). Such functional
redundancy for the CD4 downregulation implies that it
plays an essential role in the virus life cycle, even though
the biological significance remains to be elucidated. In order
to investigate the contribution of CD4 downregulation to
virus replication, the viruses harboring frame-shift muta-
tions in vpu (vpu), nef (nef), and both vpu and nef
(vpu/nef) were constructed from an HIV-1 infectious
DNA clone, pNL432, and their infectivities were examined.
A model for replication capacity of each mutant virus,
vpu, nef, or vpu/nef, is illustrated in Fig. 1A. Muta-
tion in nef is expected to affect virus replication in T-cell
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lines only moderately. It has been reported that the infec-
tivity of nef virus is reduced as compared with wildtype,
resulting in the moderate retardation of growth kinetics
(Aiken and Trono, 1995; Cowers et al., 1994). The growth
kinetics of vpu virus is comparable to that of wildtype but
the amount of virus particles released in culture supernatant
is reduced. This is likely to be due to the function of Vpu in
the enhancement of virus release from the surface of pro-
ducer cells (Strebel et al., 1988). The infectivity of the
released virions of vpu virus has been reported to be
comparable to that of wildtype (Sakai et al., 1995; Strebel et
al., 1989). Assuming that the effects of Vpu and Nef are
functionally independent, the growth profile of vpu/nef
virus is expected as shown in Fig. 1A.
Growth potentials of the mutant viruses were examined
in a T-cell line, A3.01 (Fig. 1B). Each virus having vpu or
nef mutations showed a growth profile similar to that of
the model illustrated in Fig. 1A. The double mutation in vpu
and nef (vpu/nef) caused not only reduction of virion
productivity but also severe retardation of growth kinetics.
Similar results were obtained with the infection experiment
with a different T-cell line, H9, and with PBMC (data not
shown). Such a cooperative effect by vpu and nef on
viral replication potential was previously suggested by To-
kunaga et al. (1998), and it suggested that there was a
functional linkage between Vpu and Nef functions.
Both Vpu and Nef are known to function in modulation
of CD4 expression (Chen et al., 1996), suggesting that the
phenotype observed with vpu/nef mutant was a conse-
quence of downregulation of CD4 expression. To confirm
the effect of CD4 expression on the virus replication, we
examined the infectivity of virus derived from either CD4-
positive or -negative cells using MAGI reporter cells (Fig.
2A). The mutant viruses were produced from either 293T
cells, CD4-negative human kidney-derived cells, or 293T
cells transfected with CD4 expression vector. The infectiv-
ity of wildtype virus was not affected by CD4 expression.
Nef virus showed moderately reduced infectivity as com-
pared with that of wildtype. CD4 expression caused a slight
reduction in infectivity of a nef virus in a dose-dependent
manner. The infectivity of vpu virus obtained from CD4-
negative cells was comparable to that of wildtype. It was
significantly reduced, however, when CD4 was expressed in
producer cells. The infectivity of the vpu/nef virus de-
rived from CD4-positive cells appeared to be severely im-
paired. The result of a similar experiment with viruses
derived from infected A3.01 cells resembled that of CD4-
positive 293T cells (Fig. 2B), indicating that the regulatory
effects by vpu and vpu/nef mutations on virus infectivity
were dependent upon CD4 expression in producer cells.
Cell surface CD4 does not inhibit HIV-1 virion release
The result shown in Fig. 2A indicates that the defect of
vpu and vpu/nef viruses was located in the early phase
of virus infection. It was still possible, however, that those
mutations were also affected in the late phase, such as virion
production. Ross et al., (1999) argued the effect of surface
CD4 expression on virion release. They suggested the pos-
sibility that the surface CD4 could associate with gp120 on
virions, causing trapping of virions on the cell surface. Both
Vpu and Nef function in the CD4 downregulation, suggest-
ing that the mutations in vpu and/or nef reduce the efficiency
of virion release into the culture supernatant. By introducing
CD4 expression plasmid and proviral DNA into 293T cells,
we evaluated the virion release in culture supernatant (Fig.
3). It appeared that each mutation did not affect the effi-
ciency of virion release from both CD4-negative and -pos-
itive 293T cells. The virus release was evaluated by mea-
suring reverse transcriptase (RT) activity in the supernatant
in this experiment, and we confirmed there was a linear
correlation between RT activity and the amount of p24 with
the mutant viruses used in this report (data not shown). Bour
et al. (1999) reported that the expression of cell-surface
CD4 interfered with Vpu function, resulting in inhibition of
virion release. Because 293T cells were used in this report,
Fig. 1. Replication profiles of HIV-1 vpu, nef, and vpu/nef mutants.
(A) A model of the replication profile of vpu/nef double mutants
predicted from the data previously obtained with vpu and nef mutants
(Adachi et al., 1991). (B) Growth profiles of the HIV-1 mutants. A3.01
cells were infected with each mutant (25 ng p24) on day 0 and the virus
production in the culture supernatants at the indicated days after infection
was measured by the RT assay. Three independent experiments were
performed and the representative results are shown. The incorporation of
[32P]. TTP by RT activity was quantitated with a BAS-2000 analyzer (Fuji
Film, Japan) and indicated by PSL unit.
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in which Vpu-dependent enhancement of virion release was
inactive, we cannot argue that there is an effect of interac-
tion between Vpu and surface CD4. The results obtained
here indicate that the remarkable impairment of infectivity
observed with vpu/nef mutant is due to a defect in the
early phase of infection.
A Vpu mutation causes CD4 incorporation into virions
The reduced infectivity observed with vpu and vpu/
nef viruses obtained from CD4-positive cells might be due
to the modification in the composition of viral proteins in
the virion. Lama et al. (1999) reported that mutations in vpu
and/or nef abolished CD4 downregulation, resulting in loss
of Env in virion. We examined whether such an effect was
responsible for the reduced infectivity of the vpu and
vpu/nef viruses shown in Fig. 2A. In this case, CD4-
negative 293T cells were used and the composition of viral
proteins both in the virion and the cell extract appeared not
to be affected by those mutations (Fig. 4A). By using
CD4-expressing 293T cells as the virus producer, although
some reduction of Env incorporation in virion was observed
with each mutant, there was no significant difference among
the mutants, suggesting that it was not responsible for the
drastic decrease in infectivity caused by vpu and vpu/
nef mutations. Similar analyses were performed using
infected A3.01 cells as the producer, and no significant
difference was observed in viral protein composition either
in the virion or in cell extracts between wildtype and mutant
viruses (Fig. 4B). These results indicate that the reduction of
infectivity found with vpu and vpu/nef viruses from
CD4-positive cells is not due to the consequence of the
decreased Env incorporation.
We also examined the effects of vpu and/or nef mutations
on the CD4 expression level in producer cells and virions
(Fig. 4C). With CD4-expressing 293T cells, cell-associated
CD4 was reduced with wildtype and nef viruses, but not
with vpu or vpu/nef viruses, suggesting that the total
amount of CD4 was mainly downregulated by Vpu func-
tion. CD4 molecules appeared to be significantly incorpo-
rated into vpu virions, which were augmented by vpu/nef
double mutation. CD4 incorporation into virions by vpu and
Fig. 2. The CD4-dependent effect of HIV-1 vpu, nef, and vpu/nef mutants on virion infectivity. (A) 293T cells were transfected with infectious HIV-1
DNA (5 g) with or without a CD4 expression plasmid. The amounts of input CD4 expression plasmid are indicated in the figure. By using MAGI cells as
an indicator, the infectivities of the viruses produced from transfected 293T cells were monitored. The amounts of input virus used in MAGI cell assays were
adjusted by RT activity. The infectivity of wildtype virus obtained from CD4-negative 293T cells is normalized to 100% and the relative infectivity of the
other viruses is shown. The results were obtained from at least three independent experiments, and the standard deviations are indicated with error bars. (B)
The infectivity of the viruses derived from infected A3.01 cells were evaluated by the MAGI cell assay. Viruses were harvested on the day of maximal virus
production. Equal amounts of virus, adjusted by RT activity, were used as input for the MAGI cell assay. The infectivity of wildtype virus is normalized to
100%. The results were obtained from at least three independent experiments, and the standard deviations are indicated with error bars.
Fig. 3. The effect of CD4 expression on virion release. 293T cells were
transfected with HIV-1 proviral DNA (5 g) and the indicated amounts of
CD4 expression plasmid. Virion production into culture medium was
measured by the RT assay. The production of wildtype virus from CD4-
negative cells is normalized to 100%. The results were obtained from at
least three independent experiments, and the standard deviations are indi-
cated with error bars.
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vpu/nef mutants could be also observed by using A3.01 cells
as the producer. These findings suggest that CD4 incorpo-
ration into virions contributes to the reduced infectivity of
vpu and vpu/nef viruses.
Coexpression of CD4 with Env on the virion surface may
cause association between these molecules and interfere
with the specific binding of Env to the cell surface CD4
receptor. In order to examine the inhibitory effect of virion-
associated CD4 on virion attachment, a virus attachment
assay was performed with mutant viruses produced by CD4-
negative or -positive 293T cells (Fig. 5). With CD4-nega-
tive cells, the attachment efficiencies of all mutant viruses
were comparable to those of wildtype. On the contrary, in a
comparison of attachment efficiencies of the viruses derived
from CD4-positive cells, vpu mutants were significantly
reduced in efficiency. Vpu/nef double mutants more effec-
tively abolished the attachment efficiency than single vpu
mutants. This result correlates well with those shown in
Figs. 1B and 2A. suggesting that the regulation of virus
infectivity by Vpu function was dependent on CD4 expres-
sion in producer cells and that CD4 incorporation into
virions had a negative effect on virion infectivity.
Nef functions in downregulation of surface CD4 molecule
and plays an important role in inhibiting superinfection of
HIV-1
There are many reports that describe CD4 downregula-
tion by Nef. We found that Vpu function was important for
the downregulation of the total amount of CD4 in A3.01 and
CD4-expressing 293T cells and that Nef did not signifi-
cantly affect CD4 expression (Fig. 4C). The nef mutation
we used introduced a frameshift at the 35th amino acid
position from its N-terminus, and we could not observe Nef
protein expression with the nef virus (Fig. 6A). Nef has
been reported to induce internalization of surface CD4
through a CCP-dependent transport pathway, resulting in
Fig. 5. Attachment efficiency of the virions produced from CD4-negative
or CD4-positive cells. Virions were prepared from the transfected 293T
cells as described in Fig. 2A. Virions corresponding to 100 ng of p24CA
were incubated with A3.01 and H9 cells at 4°C for 1 h. After extensive
washing, the cells were lysed and the cell extracts were applied to a p24
ELISA. The value obtained with wildtype virions derived from CD4-
negative cells was normalized to 100%. The results were obtained from at
least three independent experiments, and the standard deviations are indi-
cated with error bars. The probability from Student’s t test analysis for each
data as compared to wildtype (CD4-) is lower than 0.05 (P  0.05).
Fig. 4. Modification of the composition of viral proteins and CD4 by vpu
and/or nef mutations. (A) Viral protein expression in the transfected cells
and the produced virions were analyzed by immunoprecipitation with
anti-HIV-1 serum. Infectious HIV-1 DNA (9 g) was transfected into
293T cells with or without a CD4 expression plasmid (0.5 g). Whole cell
extracts and virion lysates were applied to a SDS–PAGE after adjusting the
input amount with the total protein and amounts of p24, respectively. The
positions of the major viral components are indicated by arrowheads. The
viral proteins invisible in whole cell extract are indicated by open arrow-
heads. (B) An analysis similar to that shown in (A) was performed with
A3.01 cells infected with HIV-1 mutants. A3.01 cells were infected and
virus production and spread of the infected cell population were monitored
each day after infection. The virion samples were harvested on the day of
maximal virus production. The cell extracts were prepared when over 90%
of cells became HIV-1 positive, which was estimated by immunostain of
the cells with anti-HIV-1 serum. (C) CD4 expression was analyzed with the
same samples used in (A) and (B). CD4 protein was detected by Western
blot analysis with CD4 antiserum. Arrowheads indicate the position of
CD4 protein.
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lysosome-dependent CD4 degradation (Greenberg et al.,
1997b; Mangasarian et al., 1997); therefore, we investigated
the surface CD4 expression on virus producer cells. Wild-
type virus strongly suppressed CD4 expression on the cell
surface (Fig. 6B). vpu, nef, and vpu/nef viruses, how-
ever, remarkably lost the effect on surface CD4 expression.
This result indicated that Nef did not affect the total amount
of CD4, but efficiently suppressed cell surface CD4 expres-
sion. Vpu downregulates surface CD4 through the degrada-
tion of intracellular CD4. Because the downregulation of
surface CD4 is considered to contribute to the inhibition of
superinfection, we examined the inhibitory effects on su-
perinfection of vpu, nef, and vpu/nef mutant viruses.
The efficiency of superinfection was evaluated by the in-
fection of HIV-1-based reporter virus into 293T cells ex-
pressing both CD4 and the mutant virus. Although the
expression of wildtype virus could effectively inhibit super-
infection, both vpu and nef viruses significantly lost such
an inhibitory effect (Fig. 6C). The cells infected with a
vpu/nef double mutant virus appeared to allow superin-
fection to the degree of the control cells (mock, CD4-
expressing 293T cells). This result indicated that both Vpu
and Nef function in inhibition of superinfection and that
Env does not play a major role in this function because Env
expression was not affected by vpu/nef mutation.
Discussion
It has been reported that the elimination of virus receptor
from cell surface is important not only for inhibition of
superinfection but also for virus replication (Lundquist et
al., 2002). In this report, we showed that the CD4 down-
regulation caused by HIV-1 infection is important for main-
tenance of virion infectivity. CD4 molecules were signifi-
cantly incorporated when CD4 downregulation was
hampered by vpu and/or nef mutations, resulting in reduced
attachment efficiency of virions to target cells. Although
Lama et al. (1999) reported that vpu and/or nef mutations
abolished Env incorporation in exchange for CD4 incorpo-
ration in virions, we could not observe the effect on Env
incorporation by the mutations. Because both they and we
used the same cell line, 293T cell, for virus producer, the
different observations could be due to the expression level
of CD4 molecules in the producer cells, but careful com-
parison of the experimental conditions is required to explain
this discrepancy. We analyzed the virion composition pro-
duced from a T-cell line, A3.01 cell, and the Env proteins
appeared to be normally incorporated in virions of vpu and
vpu/nef mutants, suggesting that these mutations have a
small effect on Env incorporation in physiological condi-
tions. Similar results were obtained with another T-cell line,
H9 (data not shown).
Vpu targets CD4 on the ER for proteasome-dependent
degradation, which decreases the total amount of CD4 as
shown in Fig. 4C (Bour et al., 1995b; Margottin et al., 1998;
Schubert et al., 1998). Although the effect of Vpu on cell
surface CD4 expression was comparable to that of Nef (Fig.
6B), the CD4 incorporation into the virion was specific to
the vpu virus. The result raised a possibility that the CD4
bound to gPr160 in the ER was transported and directly
incorporated into virions in association with Env. An early
report described that the association between CD4 and
gPr160 in the ER attenuated transport of gPr160 to the
cytoplasmic membrane and that Vpu rescued Env process-
ing by diminishing CD4 through degradation (Willey et al.,
1992b), however, our observation was in contrast to that. In
CD4-expressing 293T cells, the vpu mutant did not affect
the expression profile of Env in cells or the amount of
matured gp120 in the virion, indicating that the association
between CD4 and gPr160 did not affect the Env transport to
the cell surface, its maturation, or its incorporation into the
virion.
Although Vpu affects the total amount of CD4, Nef
appears to target the CD4 molecule on the cell surface,
which is consistent with previous reports. As we and other
groups have reported, CD4 expression in producer cells
does not contribute significantly to the Nef-mediated regu-
lation of virion infectivity (Aiken and Trono, 1995; Miller et
al., 1995). These results were, however, obtained with 293T
cells; therefore, it is possible that Nef-mediated regulation
of CD4 expression functions in enhancement of virus infec-
tivity with PBMCs. As mentioned in the report by
Fig. 6. Nef regulates virus superinfection through downregulation of sur-
face CD4 molecules. (A) 293T cells were transfected with wildtype or
mutant HIV-1 proviral DNA (9 g), and the cell extracts were analyzed for
Nef expression by Western blot with Nef antiserum. (B) 293T cells were
transfected with HIV-1 proviral DNA (9 g) with or without a CD4
expression plasmid (0.5 g). Cell surface proteins were labeled by bioti-
nylation and the whole cell extract was used in an anti-CD4 immunopre-
cipitation followed by anti-biotin Western blotting. (C) The superinfection
assay was performed with the transfected 293T cells described in (B). An
HIV-1-based reporter virus was introduced into the 293T cells and lucif-
erase activity in the cells was analyzed 1 day after infection. The luciferase
activity observed with mock-transfected 293T cells is normalized to 100%.
The results were obtained from at least three independent experiments, and
the standard deviations are indicated with error bars.
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Lundquist et al. (2002), the enhancement of virus infectivity
by Nef was found to be more drastic with the viruses
derived from PBL than with those derived from 293T and
HeLa cells. It is necessary to investigate the biological
significance of Nef-mediated CD4 downregulation in virus
replication in PBMCs.
We found a severe reduction of infectivity by the simul-
taneous mutation of vpu and nef (vpu/nef). Although the
reduction by the vpu mutation could be due to CD4 incor-
poration into virions, which by a nef mutation has been
reported to be mostly independent of CD4 expression
(Aiken and Trono, 1995; Miller et al., 1995). As shown in
Fig. 2A; however, the infectivity of nef virus was reduced
with higher levels of CD4 expression, indicating that the
downregulation of CD4 was partially involved in Nef-me-
diated promotion of virus infectivity. CD4-dependent regu-
lation of virus infectivity by Nef is also supported by the
fact that CD4 incorporation into virions is stimulated by
vpu/nef to a larger extent than by a vpu mutation. The
regulation of virus infectivity by Nef through CD4 down-
regulation could be suppressed in the presence of Vpu and
may become noticeable in the absence of Vpu. It might be
also possible that CD4-independent enhancement of virus
infectivity by Nef is augmented by the vpu viruses which
are defective for the attachment process.
A major purpose of Nef-mediated CD4 downregulation
is likely to be the inhibition of HIV-1 superinfection, be-
cause Nef directs downregulation of cell-surface CD4, and
that the Nef-mediated regulation of virus infectivity is
mostly CD4-independent. It has been reported that superin-
fection of HIV-1 induces a cytotoxic effect, suggesting that
the inhibition of superinfection is beneficial to efficient
virus replication (Bergeron and Sodroski, 1992; Pauza et al.,
1990; Robunson and Zinkus, 1990; Somasundaran and Rob-
inson, 1988). However, this result was obtained by in vitro
tissue culture studies, and therefore it needs to be investi-
gated whether similar effects are observed under in vivo
conditions. In infected individuals, superinfection may be-
come permissive in latently infected cells, in which the
expression of viral genes, including vpu and nef, are sup-
pressed. In the multiply infected cells, recombination be-
tween viruses might produce an adapted virus under selec-
tive pressure from the host immune system, suggesting that
superinfection may not be necessarily harmful for virus
replication in vivo. Therefore, it is necessary to examine the
significance of superinfection in in vivo studies (Le Guern
and Levy, 1992; Robertson et al., 1995a, 1995b).
In this report, we described that CD4 downregulation
caused by HIV-1 regulatory gene products is required for
maintenance of virus infectivity, even though it remains
unknown whether or not it is a major function of CD4
modulation in the virus life cycle. Although it is necessary
to further investigate the molecular mechanism of Vpu- and
Nef-mediated CD4 regulation and its contribution to virus
replication, the results presented in this report raise the
possibility that a mutant CD4 molecule resistant to Vpu-
and Nef-mediated degradation would be a good candidate
for anti-HIV reagents.
Materials and methods
Cell culture and DNA transfections
293T cells were maintained in Dulbecco’s modified Ea-
gle’s medium (DMEM) containing 10% heat-inactivated
fetal bovine serum (FBS). The CD4-positive T-cell lines
A3.01 (Folks et al., 1985) and H9 (Popovic et al., 1984)
were maintained in RPMI 1640 medium containing 10%
FBS. Hela–CD4–LTR–-gal cells (MAGI cells: multinu-
clear activation of a galactosidase indicator) (Kimpton and
Emerman, 1992) were propagated in DMEM supplemented
with 10% FBS, 0.2 mg/ml G418 (Nacalai Tesque, Japan),
and 0.1 mg/ml hygromycin B (Sigma–Aldrich Corp., St.
Louis, MO). The calcium phosphate coprecipitation (Ni-
shimura et al., 2000) was used for transfection. Cells (5 
105) were seeded in a 6-cm dish 1 day prior to transfection.
Plasmid and carrier DNA (total 10 g) were incubated with
500 l of Hepes-buffered saline (HBS) transfection buffer
[140 mM NaCl, 0.75 mM Na2HPO4, 25 mM Hepes, 110
mM CaCl2] (pH6.90) for 30 min at room temperature and
then added to a culture dish. At 20 h after transfection, cells
were washed once with phosphate-buffered saline (PBS)
and fresh growth medium was added.
Reverse transcriptase (RT) assay
The RT assay was performed as described previously
(Willey et al., 1988). Virus-containing culture medium was
mixed with the RT assay cocktail [50 mM Tris · HCl
(pH8.0), 75 mM KCl, 10 mM dithiothreitol (DTT), 4.95
mM MgCl2, 10 g/ml polyA, 5 g/ml oligo dT, 0.05%
(v/v) NP40, 0.4 MBq [-32P]TTP] and incubated for 1 h at
37°C. DE81 (Whatman International Ltd., Maidstone, En-
gland) was spotted with the reaction mixture and then
washed with 2  SSC [0.3 M NaCl, 30 mM sodium citrate
(pH 7.0)]. Incorporated radioactivity was quantitated with a
BAS2000 bioimaging analyzer (Fuji Film, Japan), by which
the values were obtained as photo-stimulated luminescence
(PSL) unit.
Virus replication assay
A3.01 cells (1  106 cells) were infected with the virus
stock (25 ng p24) for 5 h in the presence of 8 g/ml
polybrene and then fresh growth medium (3.5ml) was added
to the cells. The amounts of input virus were adjusted by RT
activity. On the indicated days after infection, the culture
supernatant was harvested and RT activity in the superna-
tant was quantified.
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DNA constructs
An infectious proviral clone of HIV-1, pNL432 (wild-
type) (Adachi et al., 1986), and its mutants, designated
pNL-Ss (vpu mutant), pNL-Xh (nef mutant), and
pNL-Kp (env mutant), have been previously described
(Adachi et al., 1991). pNL-SsXh (vpu/nef double mu-
tant) was constructed from pNL-Ss by introducing frame-
shift mutation in the nef coding region (XhoI site). The
pNL–rev–luc was constructed from pNL432 which con-
tains a point mutation at the rev ATG initiation codon (ATG
was substituted with ATC) and an insertion of the luciferase
coding gene (derived from pGL3-basic, BD Biosciences
Clontech, Palo Alto, CA) in the nef region (XhoI site). The
rev expression plasmid, pCMV–F-Rev, was described pre-
viously (Ono et al., 2000). CD4 expression plasmid,
pCMV4–CD4 was constructed by inserting the CD4 coding
DNA derived from T4–pMV7 into the pCMV4 expression
plasmid (Del Vecchio et al., 1992). T4–pMV7 was obtained
through the NIH AIDS Research and Reference Reagent
Program, Division of AIDS, NIAID, NIH, from Dr. Richard
Axel (Maddon et al., 1986).
MAGI cell assay
MAGI cells were infected with virus stock (adjusted with
the RT activity) in the presence of 8 g/ml polybrene, and
the -galactosidase activity in the cells was monitored at
72 h after infection by the Luminescent -gal Reporter
System 3 (BD Biosciences Clontech, Palo Alto, CA).
Preparation of cell extracts and virions
The cells were lysed in RIPA buffer [150 mM NaCl,
50mM Tris · HCl (pH8.0), 0.1% sodium dodecyl sulfate
(SDS), 1% Nonidet P-40, 0.5% sodium deoxycholate, 1 mM
DTT, 16 g/ml benzamidine HCl, 10 g/ml phenanthro-
line, 10 g/ml aprotinin, 10 g/ml leupeptin, 10 g/ml
pepstatin A, 1 mM PMSF]. Virion-containing culture me-
dium was loaded onto 20%/65% discontinuous sucrose gra-
dient and centrifuged at 30 krpm for 2 h (RPS-40T rotor,
Hitachi Koki Co., Ltd., Japan). The interphase of the su-
crose gradient was collected and the virions were pelleted
by ultracentrifugation (30 krpm, 2 h, 4°C). The virion pellet
was resuspended in RIPA buffer.
Western blot analysis
Cell extracts and virion samples were loaded on 10%
SDS–polyacrylamide gel electrophoresis (PAGE). The pro-
teins were transferred onto Hybond–PVDF membrane (Am-
ersham Biosciences Corp., Piscataway, NJ) and Nef and
CD4 proteins were detected with HIV-1 Nef antiserum
(Shugars et al., 1993) and CD4 antiserum (T4-4) (Deen et
al., 1988; Willey et al., 1992b) (NIH AIDS Research and
Reference Reagent Program, Division of AIDS, NIAID,
NIH), respectively. For visualization, a chemiluminescent
detection reagent (Lumi-Light Western Blotting Substrate,
Roche Diagnostics GmbH, Mannheim, Germany) was used.
Metabolic labeling and immunoprecipitation
At 48 h posttransfection of the proviral DNA clones into
293T cells, the cells were labeled for 12 h with Pro-mix
L-[35S] in vitro cell labeling mix (Amersham Biosciences
Corp., Piscataway, NJ). The cell extracts and virus particles
were prepared in RIPA buffer. Viral proteins were precip-
itated with anti-HIV-1 serum (NIH AIDS Research and
Reference Reagent Program, Division of AIDS, NIAID,
NIH, HIV-1 neutralizing serum(1)) (Vujcic and Quinnan,
1995) plus protein G–agarose (Invitrogen Corp., Carlsbad,
CA) and separated through 10% SDS–PAGE. The gel im-
age was obtained by exposure to BioMax MS films (East-
man Kodak Company, Rochester, NY).
Cell surface protein analysis
The cells were washed three times with PBS, biotinyl-
ated at 4°C for 30 min with 0.5 mg/ml of NHS-SS-Biotin
(Pierce, Rockford, IL) in PBS, and lysed with RIPA buffer.
The cell extracts were precipitated with CD4 antiserum
(T4-4) and protein G–agarose and then separated on 10%
SDS–PAGE. The biotinylated CD4 was detected by West-
ern blot analysis with anti-biotin monoclonal antibody
(Jackson Immuno Research Laboratories, Inc., West Grove,
PA).
Virion attachment assay
For the attachment assay, A3.01 and H9 cells (1  106
cells) were incubated with viruses (100 ng p24). After 1 h of
incubation at 4°C, unbound virions were removed by wash-
ing with ice-cold PBS containing 1% FBS. The cells were
lysed in a lysis buffer [0.5% (v/v) NP-40, 10 mM NaCl, 10
mM Tris · HCl (pH7.5)], and then the amount of cell-
associated p24 in the cell extract was determined with a p24
ELISA (ZeptoMetrix Corp., Buffalo, NY).
Superinfection assay
293T cells were transfected with HIV-1 proviral DNA (9
g), pCMV4–CD4 (0.5 g), and pGreenLantern-1 (Invitro-
gen Corp., Carlsbad, CA). The transfection efficiency was
monitored by the expression of green fluorescence protein
and the samples over 90% transfection efficiency were used
for the assay. Two days after transfection, the cells were
infected with an HIV-based reporter virus in the presence of
polybrene (8 mg/ml). At 24 h postinfection, the cells were
harvested and analyzed for luciferase expression by the
Luciferase Assay System (Promega Corp., Madison, WI).
Reporter virus was obtained from 293T cells transfected
with pNL–rev–luc (9.5 g) and pCMV–F-rev (0.5 g).
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